Results for:(14 found)
Jun 2, 2014 2:46PM on Top StocksBy MSN Money Partner

Companies presented data on their drugs, and investors responded by punishing or rewarding shares.

Jul 18, 2013 10:58AM on Top StocksBy MSN Money Partner

Cabot Oil & Gas is initiated with an 'overweight,' and Merck is downgraded to 'market perform.'

Jun 11, 2013 11:27AM on Top StocksBy TheStreet Staff

In a bubbly year for the biotech sector, these five stocks stand out over the rest -- some may surprise you.

May 29, 2013 11:31AM on Top StocksBy TheStreet Staff

The FDA should make a speedy review of the breakthrough cancer drug a top priority.

May 13, 2013 10:23AM on Top StocksBy MSN Money Partner

Aeropostale is downgraded to 'neutral,' and Warner Chilcott is upgraded to 'buy.'

Apr 11, 2013 9:23AM on Top StocksBy Benzinga

Amgen, Celgene and Pharmacyclics see short interest drop recently.

Mar 28, 2013 10:50AM on Top StocksBy Benzinga

There's mixed interest in biotech, biopharmaceutical and emerging pharma companies.

Feb 13, 2013 12:14PM on Top StocksBy Minyanville.com

The classification of ibrutinib as a breakthrough therapy could mean speedy approval by the agency.

Tags: JNJPCYC

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.